Global Interventional Neurology Devices Market 2017-2021

  • ID: 4380400
  • Report
  • Region: Global
  • 86 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer
  • DePuy Synthes
  • Merit Medical Systems
  • Penumbra
  • Surtex Instruments
  • MORE
About Interventional Neurology Devices

Interventional neurology is a specialty that uses minimally invasive, image-guided techniques to treat most of the complex and dangerous diseases of the brain, neck, and spine. Education and research are the main components of the interventional neurology services. The procedures performed by the interventional neurologists are complex. The primary aim is to minimize the risk to the patient by application of image guidance and minimally invasive techniques. The interventional neurologists specialize in the manipulation of needles and the use of fine catheter tubes and wires to navigate around the body using imaging control.

The analysts forecast the global interventional neurology devices market to grow at a CAGR of 7.50% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global interventional neurology devices market for 2017-2021. To calculate the market size, the report considers the total sales volume and revenue generated from interventional neurology devices.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Interventional Neurology Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • DePuy Synthes
  • Medtronic
  • Stryker
  • TERUMO
Other prominent vendors
  • Acandis
  • B. Braun Melsungen
  • Bayer
  • Boston Scientific
  • Biosensors International
  • evonos
  • Merit Medical Systems
  • MicroPort Scientific
  • Neurosign
  • Penumbra
  • Spiegelberg
  • Surtex Instruments
  • W. L. Gore & Associates
Market drivers
  • Increase in incidence of neurological disorders
  • For a full, detailed list, view the full report
Market challenges
  • Inadequate and inequitably distributed resources
  • For a full, detailed list, view the full report
Market trends
  • Increased funding for R&D of neurotherapies
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer
  • DePuy Synthes
  • Merit Medical Systems
  • Penumbra
  • Surtex Instruments
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by product
  • Market overview
PART 07: Market segmentation by application
  • Market overview
PART 08: Market segmentation by end-user
  • Market overview
  • Hospitals
  • ASCs
PART 09: Geographical segmentation
  • Market scenario
  • Americas
  • EMEA
  • APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Market challenges
PART 12: Market trends

PART 13: Vendor landscape
  • Competitive landscape
  • Other prominent vendors
PART 14: Key vendor analysis
  • Abbott
  • DePuy Synthes
  • Medtronic
  • Stryker
  • TERUMO
PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Market scenario for interventional neurology devices (2016-2021)
Exhibit 02: Global interventional neurology devices market: Overview
Exhibit 03: Global interventional neurology devices market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Segmentation of global interventional neurology devices market by end-user 2016 (%)
Exhibit 06: Segmentation of global interventional neurology devices market by end-user 2021 (%)
Exhibit 07: Global interventional neurology devices market by hospitals 2016-2021 ($ millions)
Exhibit 08: Global interventional neurology devices market by ASCs 2016-2021 ($ millions)
Exhibit 09: Global interventional neurology devices market by geography 2016 (%)
Exhibit 10: Global interventional neurology devices market by geography 2021 (%)
Exhibit 11: Global interventional neurology devices market overview by geography 2016 and 2021
Exhibit 12: Interventional neurology devices market in Americas 2016-2021 ($ millions)
Exhibit 13: Interventional neurology devices market in EMEA 2016-2021 ($ millions)
Exhibit 14: Interventional neurology devices market in APAC 2016-2021 ($ millions)
Exhibit 15: Reimbursement for interventional neurology procedures
Exhibit 16: Cost of CAS by different vendors
Exhibit 17: Abbott: Key highlights
Exhibit 18: Abbott: Strength assessment
Exhibit 19: Abbott: Strategy assessment
Exhibit 20: Abbott: Opportunity assessment
Exhibit 21: DePuy Synthes: Key highlights
Exhibit 22: DePuy Synthes: Strength assessment
Exhibit 23: DePuy Synthes: Strategy assessment
Exhibit 24: DePuy Synthes: Opportunity assessment
Exhibit 25: Medtronic: Key highlights
Exhibit 26: Medtronic: Strength assessment
Exhibit 27: Medtronic: Strategy assessment
Exhibit 28: Medtronic: Opportunity assessment
Exhibit 29: Stryker: Global sales by segment 2016 (%)
Exhibit 30: Stryker: Key highlights
Exhibit 31: Stryker: Strength assessment
Exhibit 32: Stryker: Strategy assessment
Exhibit 33: Stryker: Opportunity assessment
Exhibit 34: TERUMO: Sales by geography FY 2015 (%)
Exhibit 35: TERUMO: Key highlights
Exhibit 36: TERUMO: Strength assessment
Exhibit 37: TERUMO: Strategy assessment
Exhibit 38: TERUMO: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Bayer
  • DePuy Synthes
  • Merit Medical Systems
  • Penumbra
  • Surtex Instruments
  • MORE
New Report Released: - Global Interventional Neurology Devices Market 2017-2021

The author of the report recognizes the following companies as the key players in the global interventional neurology devices market: Abbott, DePuy Synthes, Medtronic, Stryker, and TERUMO.

Other Prominent Vendors in the market are: Acandis, B. Braun Melsungen, Bayer, Boston Scientific, Biosensors International, evonos, Merit Medical Systems, MicroPort Scientific, Neurosign, Penumbra, Spiegelberg, Surtex Instruments, and W. L. Gore & Associates

Commenting on the report, an analyst from the research team said: “One trend in the market is increased funding for R&D of neurotherapies. Currently, the government is providing funding for multiple R&D projects to encourage innovations and technical advances in brain monitoring devices. Many government and non-government agencies are collaborating for the prevention and control of neurological diseases like epilepsy, MS, and brain tumors. They are emphasizing on preventive care compared to curative care.”

According to the report, one driver in the market is increase in incidence of neurological disorders. Over the years, the global health effect of neurological disorders has been underestimated. The neurological services and resources are excessively scarce, particularly in low income and developing countries. Neurological disease is a growing and a severe problem in various parts of the world, which includes the US, Canada, Europe, China, India, and Germany. One of the most common neurological diseases is multiple sclerosis. It is diagnosed by using electroencephalogram to record brainwaves in response to different stimuli. It is most prevalent in Northern Europe, North America, Australia, and New Zealand.

Further, the report states that one challenge in the market is inadequate and inequitably distributed resources. Neurological conditions are causing enormous burden, but they are mostly absent from the international health program. Also, health plans in many countries often do not cover neurological disorders at the equal level as other illnesses, which results in substantial economic problems for patients and their families. In the least developed countries of the world, poor people have higher chances to develop neurological disorders than wealthy people. The people in the least developed countries are not aware about the certain preventive measures that can be taken in the initial stage of diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • DePuy Synthes
  • Medtronic
  • Stryker
  • TERUMO
  • Acandis
  • B. Braun Melsungen
  • Bayer
  • Boston Scientific
  • Biosensors International
  • evonos
  • Merit Medical Systems
  • MicroPort Scientific
  • Neurosign
  • Penumbra
  • Spiegelberg
  • Surtex Instruments
  • W. L. Gore & Associates
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll